NIPH Clinical Trials Search

UMIN ID: UMIN000002209

Registered date:17/07/2009

Blood-based Early Detection Tests for Gastric Cancer Program, Pilot Clinical Study (Phase I)

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedGastric Cancer
Date of first enrollment2009/08/01
Target sample size250
Countries of recruitmentJapan
Study typeObservational


Primary OutcomeSensitivity and specificity of biomarhkers
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaSubject was taking experimental drug or anticancer drug within the past 30 days. Subject has been confirmed as having cancer in the past. Subject was confirmed as having cancer excluding gastric cancer at present. Major trauma or surgery within the past 3 months before study procedure. Subject is considered by the investigator to be an unsuitable candidate for this study. Known or suspected infection with human immunodeficiency virus or infectious hepatitis.

Related Information


public contact
Name Masahiro Sakabe
Address 18F STEC Jyoho Building 1-24-1 Nishi-Shinjuku Shinjuku-ku, Tokyo 160-0023 Japan Japan
Affiliation Alere Medical Co., Ltd. Technical Support
scientific contact
Name Toshiharu Yamaguchi
Address 3-8-31 Ariake Kohtoh-ku Tokyo 135-8550, Japan Japan
Affiliation Cancer Institute Ariake Hospital Gastroenterological Center